Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy

• Published in: Clinical and molecular hepatology Vol. 26; no. 3; pp. 251 - 260
• Main Authors: Huang, Chung-Feng, Yu, Ming-Lung
• Format: Journal Article
• Language: English
• Published: Korea (South) Korean Association for the Study of the Liver 01.07.2020; The Korean Association for the Study of the Liver; 대한간학회
• Subjects: Antiviral drugs; direct-acting antivirals; Failure; Genotype & phenotype; Hepatitis B; Hepatitis C; hepatitis c virus; Infections; Liver cancer; Liver cirrhosis; Liver diseases; Liver transplants; Mortality; Mutation; Review; treatment; 내과학; Hepatitis C virus; Treatment; Direct-acting antivirals
• ISSN: 2287-2728; 2287-285X; 2287-285X
• DOI: 10.3350/cmh.2020.0018

The treatment of chronic hepatitis C (CHC) has been revolutionized in an era of all-oral direct-acting antivirals (DAAs) since 2014. Satisfactory treatment efficacy and tolerability can be provided by novel DAAs. Nevertheless, there are still some unmet needs and emerging issues in the treatment of...